SynthesisFrontiers in endocrinology2022

Efficacy and Safety of Empagliflozin on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Yuyuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.